Expression and characterization of hepatitis E virus-like particles and non-virus-like particles from insect cells

Biotechnology and Applied Biochemistry

Volumn 63, Issue 3, 2016, Pages 362-370

  Qi, Ying ^a,b   Fan, Jinping ^b   Huang, Weijin ^b   Zhao, Chenyan ^b   Wang, Youchun ^b   Kong, Franklin T ^c   Kong, Wei ^a   Jiang, Chunlai ^a  

^a JILIN UNIVERSITY   (China)

^b NATIONAL INSTITUTES FOR FOOD AND DRUG CONTROL   (China)

^c Pioneer High School   (United States)

Author keywords

capsid protein; hepatitis E virus; non virus like particle; particle assembly; virus like particles

Indexed keywords

CELL CULTURE; CELLS; CYTOLOGY; PROTEINS; PURIFICATION; VACCINES;

CAPSID PROTEINS; HEPATITIS E VIRUS; HUMORAL IMMUNE RESPONSE; INSECT CELL CULTURE; PARTICLE ASSEMBLIES; PHYSICOCHEMICAL PROPERTY; PURIFICATION METHOD; VIRUS-LIKE PARTICLES;

VIRUSES;

CAPSID PROTEIN; CELL PROTEIN;

ANIMAL CELL; ANION EXCHANGE CHROMATOGRAPHY; CELL LYSATE; CELL VIABILITY; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; FEMALE; HEPATITIS E VIRUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMORAL IMMUNITY; HYDRODYNAMICS; IMMUNOGENICITY; INSECT CELL; INSECT CELL CULTURE; ION EXCHANGE CHROMATOGRAPHY; MOUSE; NONHUMAN; PEPTIDE MAPPING; PHOTON CORRELATION SPECTROSCOPY; PHYSICAL CHEMISTRY; PROTEIN ISOLATION; PROTEIN PURIFICATION; REVIEW; SEPARATION TECHNIQUE; SF9 CELL LINE; SUSPENSION CELL CULTURE; VIRUS EXPRESSION; VIRUS IMMUNITY; VIRUS ISOLATION; VIRUS LIKE AGENT; VIRUS PURIFICATION;

EID: 84975047143     PISSN: 08854513     EISSN: 14708744     Source Type: Journal    
DOI: 10.1002/bab.1379     Document Type: Review

References (32)

1. Khuroo, M. S., Teli, M. R., Skidmore, S., and Sofi, M. A., Khuroo, M. I. (1981) Am. J. Med. 70, 252–255.
2. Khuroo, M. S., and Kamili, S. (2003) J. Viral Hepat. 10, 61–69.
3. Balayan, M. S., Andjaparidze, A. G., Savinskaya, S. S., Ketiladze, E. S., Braginsky, D. M., Savinov, A. P., and Poleschuk, V. F. (1983) Intervirology 20, 23–31.
4. FitzSimons, D., Hendrickx, G., Vorsters, A., and VanDamme, P. (2010) Vaccine 28, 583–588.
5. Li, T. C., Chijiwa, K., Sera, N., Ishibashi, T., Etoh, Y., Shinohara, Y., Kurata, Y., Ishida, M., Sakamoto, S., Takeda, N., and Miyamura, T. (2005) Emerg. Infect. Dis. 11, 1958–1960.
6. Matsubayashi, K., Nagaoka, Y., Sakata, H., Sato, S., Fukai, K., Kato, T., Takahashi, K., Mishiro, S., Imai, M., Takeda, N., and Ikeda, H. (2004) Transfusion 44, 934–940.
7. Bihl, F., and Negro, F. (2010) J. Antimicrob. Chemother. 65, 817–821.
8. Liu, P., Li, L., Wang, L., Bu, Q., Fu, H., Han, J., Zhu, Y., Lu, F., and Zhuang, H. (2012) Infect. Genet. Evol. 12, 428–434.
9. Emerson, S. U., Anderson, D., Arankalle, A., Meng, X. J., Purdy, M., Schlauder, G. G., and Tsarev, S. A. (2005) Fields Virol- ogy., Elsevier/Academic Press, London, pp. 853–857.
10. Chandra, V., Taneja, S., Kalia, M., and Jameel, S. (2008) J. Biosci. 33, 451–464.
11. Korkaya, H., Jameel, S., Gupta, D., Tyagi, S., Kumar, R., Zafrullah, M., Mazumdar, M., Lal, S. K., Xiaofang, L., Sehgal, D., Das, S. R., and Sahal, D. (2001) J. Biol. Chem. 276, 42389–42400.
12. Dingle, K. E., Lambden, P. R., Caul, E. O., and Clarke, I. N. (1995) J. Gen. Virol. 76 (Pt 9), 2349–2355.
13. Kajigaya, S., Fujii, H., Field, A., Anderson, S., Rosenfeld, S., Anderson, L. J., Shimada, T., and Young, N. S. (1991) Proc. Natl. Acad. Sci. USA 88, 4646–4650.
14. Li, T. C., Takeda, N., Miyamura, T., Matsuura, Y., Wang, J. C., Engvall, H., Hammar, L., Xing, L., and Cheng, R. H. (2005) J. Virol. 79, 12999–13006.
15. Li, T. C., Yamakawa, Y., Suzuki, K., Tatsumi, M., Razak, M. A., Uchida, T., Takeda, N., and Miyamura, T. (1997) J. Virol. 71, 7207–7213.
16. Xing, L., Kato, K., Li, T., Takeda, N., Miyamura, T., Hammar, L., and Cheng, R. H. (1999) Virology 265, 35–45.
17. Xing, L., Li, T. C., Mayazaki, N., Simon, M. N., Wall, J. S., Moore, M., Wang, C. Y., Takeda, N., Wakita, T., Miyamura, T., and Cheng, R. H. (2010) J. Biol. Chem. 285, 33175–33183.
18. Bernard, A., Payton, M., and Radford, K. R. (2001) Current Protocols in Neuroscience, Glaxo Institute for Molecular Biology, Geneva, Switzerland, Chapter 4, Unit 4 19.
19. Ma, H., Song, X., Harrison, T. J., Zhang, H., Huang, W., Wang, Y. (2011) J. Med. Virol. 83, 827–832.
20. Bernard, A., Payton, M., and Radford, K. R. (2001) Current Protocols in Protein Science, Glaxo Institute for Molecular Biology, Geneva, Switzerland, Chapter 5, Unit5 5.
21. Li, T., Takeda, N., and Miyamura, T. (2001) Vaccine 19, 3476–3484.
22. White, L. J., Hardy, M. E., and Estes, M. K. (1997) J. Virol. 71, 8066–8072.
23. Peixoto, C., Sousa, M. F., Silva, A. C., Carrondo, M. J., and Alves, P. M. (2007) J. Biotechnol. 127, 452–461.
24. Sedlik, C., Saron, M., Sarraseca, J., Casal, I., and Leclerc, C. (1997) Proc. Natl. Acad. Sci. USA 94, 7503–7508.
25. Robinson, R. A., Burgess, W. H., Emerson, S. U., Leibowitz, R. S., Sosnovtseva, S. A., Tsarev, S., and Purcell, R. H. (1998) Protein Express. Purif. 12, 75–84.
26. Sehgal, D., Malik, P. S., and Jameel, S. (2003) Protein Express. Purif. 27, 27–34.
27. Guu, T. S., Liu, Z., Ye, Q., Mata, D. A., Li, K., Yin, C., Zhang, J., and Tao, Y. J. (2009) Proc. Natl. Acad. Sci. USA 106, 12992–12997.
28. Yamashita, T., Mori, Y., Miyazaki, N., Cheng, R. H., Yoshimura, M., Unno, H., Shima, R., Moriishi, K., Tsukihara, T., Li, T. C., Takeda, N., Miyamura, T., and Matsuura, Y. (2009) Proc. Natl. Acad. Sci. USA 106, 12986–12991.
29. Zhang, M., Emerson, S. U., Nguyen, H., Engle, R. E., Govindarajan, S., Gerin, J. L., and Purcell, R. H. (2001) Vaccine 20, 853–857.
30. Kamili, S. (2011) Virus Res. 161, 93–100.
31. Li, T. C., Suzaki, Y., Ami, Y., Dhole, T. N., Miyamura, T., and Takeda, N. (2004) Vaccine 22, 370–377.
32. Wang, C. Y., Miyazaki, N., Yamashita, T., Higashiura, A., Nakagawa, A., Li, T. C., Takeda, N., Xing, L., Hjalmarsson, E., Friberg, C., Liou, D. M., Sung, Y. J., Tsukihara, T., Matsuura, Y., Miyamura, T., and Cheng, R. H. (2008) Acta Crystallogr. Sect. F Struct. Biol. Crystall. Commun. 64, 318–322.